Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dopamine | 11 | 2014 | 245 | 2.120 |
Why?
|
S-Adenosylmethionine | 11 | 2008 | 38 | 1.470 |
Why?
|
Levodopa | 6 | 2014 | 20 | 1.430 |
Why?
|
Parkinson Disease | 6 | 2012 | 178 | 1.260 |
Why?
|
Antiparkinson Agents | 3 | 2014 | 12 | 1.190 |
Why?
|
Corpus Striatum | 6 | 2014 | 104 | 1.010 |
Why?
|
Parkinsonian Disorders | 3 | 2014 | 37 | 1.000 |
Why?
|
Tyrosine 3-Monooxygenase | 7 | 2012 | 78 | 0.880 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 5 | 2014 | 13 | 0.770 |
Why?
|
Methanol | 2 | 2012 | 18 | 0.760 |
Why?
|
Catechol O-Methyltransferase | 2 | 2014 | 12 | 0.590 |
Why?
|
Behavior, Animal | 5 | 2012 | 314 | 0.590 |
Why?
|
Lysophosphatidylcholines | 3 | 2005 | 22 | 0.560 |
Why?
|
Tyrosine | 2 | 2007 | 118 | 0.540 |
Why?
|
Aromatic-L-Amino-Acid Decarboxylases | 2 | 2012 | 3 | 0.510 |
Why?
|
Methylation | 8 | 2014 | 113 | 0.490 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2012 | 162 | 0.460 |
Why?
|
Motor Activity | 5 | 2010 | 418 | 0.450 |
Why?
|
Disease Models, Animal | 3 | 2014 | 1371 | 0.410 |
Why?
|
Rats, Sprague-Dawley | 11 | 2008 | 1618 | 0.400 |
Why?
|
Rats | 15 | 2008 | 3483 | 0.390 |
Why?
|
Mice, Inbred C57BL | 6 | 2014 | 1609 | 0.390 |
Why?
|
Dopamine Antagonists | 3 | 2007 | 44 | 0.370 |
Why?
|
Brain Chemistry | 5 | 2007 | 140 | 0.370 |
Why?
|
Animals | 21 | 2014 | 15081 | 0.370 |
Why?
|
MPTP Poisoning | 2 | 2006 | 11 | 0.340 |
Why?
|
Formates | 1 | 2008 | 5 | 0.330 |
Why?
|
Formaldehyde | 1 | 2008 | 33 | 0.330 |
Why?
|
Brain | 3 | 2004 | 1346 | 0.320 |
Why?
|
Paraquat | 1 | 2006 | 21 | 0.280 |
Why?
|
Mice | 7 | 2014 | 5913 | 0.270 |
Why?
|
Neurotoxins | 1 | 2006 | 57 | 0.260 |
Why?
|
Homocysteine | 1 | 2005 | 19 | 0.260 |
Why?
|
Neurotoxicity Syndromes | 1 | 2005 | 35 | 0.250 |
Why?
|
Methionine | 2 | 2002 | 30 | 0.240 |
Why?
|
Male | 16 | 2014 | 20025 | 0.240 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 2003 | 8 | 0.240 |
Why?
|
Receptors, Dopamine | 1 | 2004 | 25 | 0.230 |
Why?
|
Cystine | 1 | 2003 | 14 | 0.230 |
Why?
|
Membrane Transport Proteins | 1 | 2004 | 95 | 0.230 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 211 | 0.210 |
Why?
|
Substantia Nigra | 3 | 2005 | 44 | 0.210 |
Why?
|
Parkinson Disease, Secondary | 2 | 2011 | 10 | 0.210 |
Why?
|
Chromatography, High Pressure Liquid | 4 | 2007 | 421 | 0.200 |
Why?
|
Nerve Tissue Proteins | 1 | 2004 | 360 | 0.200 |
Why?
|
Methionine Adenosyltransferase | 2 | 2004 | 2 | 0.180 |
Why?
|
Cell Differentiation | 1 | 2002 | 587 | 0.170 |
Why?
|
Homovanillic Acid | 2 | 2010 | 10 | 0.160 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 2 | 2010 | 27 | 0.160 |
Why?
|
Injections, Intraventricular | 3 | 2005 | 64 | 0.150 |
Why?
|
PC12 Cells | 3 | 2007 | 93 | 0.140 |
Why?
|
Nerve Degeneration | 2 | 1994 | 107 | 0.140 |
Why?
|
Pregnancy | 2 | 2012 | 1549 | 0.140 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 2 | 2007 | 50 | 0.130 |
Why?
|
Benzazepines | 2 | 2007 | 32 | 0.130 |
Why?
|
Receptors, Dopamine D1 | 2 | 2007 | 40 | 0.130 |
Why?
|
Phosphatidylethanolamine N-Methyltransferase | 2 | 2005 | 6 | 0.130 |
Why?
|
Neurons | 1 | 2002 | 1175 | 0.130 |
Why?
|
Apoptosis | 1 | 2002 | 1398 | 0.120 |
Why?
|
Cell Survival | 2 | 2008 | 864 | 0.120 |
Why?
|
Drug Synergism | 2 | 2006 | 177 | 0.120 |
Why?
|
Phospholipids | 2 | 2005 | 70 | 0.120 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 143 | 0.120 |
Why?
|
1-Methyl-4-phenylpyridinium | 2 | 2005 | 30 | 0.120 |
Why?
|
Movement Disorders | 1 | 1993 | 8 | 0.110 |
Why?
|
Kinetics | 2 | 2005 | 708 | 0.110 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 431 | 0.110 |
Why?
|
alpha-Synuclein | 1 | 2012 | 52 | 0.100 |
Why?
|
Catecholamines | 2 | 2007 | 44 | 0.100 |
Why?
|
Birth Weight | 1 | 2010 | 90 | 0.090 |
Why?
|
Time Factors | 1 | 2014 | 1742 | 0.090 |
Why?
|
Respiratory Muscles | 1 | 1988 | 10 | 0.080 |
Why?
|
Muscles | 1 | 1988 | 82 | 0.080 |
Why?
|
Female | 3 | 2012 | 20969 | 0.080 |
Why?
|
Respiration | 1 | 1988 | 58 | 0.080 |
Why?
|
Motor Neurons | 1 | 1988 | 83 | 0.070 |
Why?
|
Mitochondrial Membranes | 1 | 2007 | 40 | 0.070 |
Why?
|
Membrane Potentials | 1 | 2007 | 223 | 0.070 |
Why?
|
S-Adenosylhomocysteine | 2 | 2005 | 9 | 0.070 |
Why?
|
Synaptic Transmission | 1 | 2007 | 146 | 0.070 |
Why?
|
Blotting, Western | 1 | 2008 | 859 | 0.070 |
Why?
|
Gene Expression Regulation | 1 | 2011 | 1015 | 0.070 |
Why?
|
Herbicides | 1 | 2006 | 44 | 0.070 |
Why?
|
Catheterization | 1 | 2005 | 24 | 0.070 |
Why?
|
Neostriatum | 1 | 2005 | 26 | 0.060 |
Why?
|
Aging | 1 | 2010 | 664 | 0.060 |
Why?
|
Hypokinesia | 1 | 2005 | 3 | 0.060 |
Why?
|
Quinacrine | 1 | 2005 | 5 | 0.060 |
Why?
|
Chromatography, Thin Layer | 1 | 2005 | 37 | 0.060 |
Why?
|
Adenosine | 1 | 2005 | 59 | 0.060 |
Why?
|
Pyridinium Compounds | 1 | 2005 | 27 | 0.060 |
Why?
|
Pineal Gland | 1 | 2004 | 31 | 0.060 |
Why?
|
Reactive Oxygen Species | 1 | 2007 | 461 | 0.060 |
Why?
|
Mazindol | 1 | 2004 | 4 | 0.060 |
Why?
|
Methyltransferases | 1 | 2005 | 58 | 0.060 |
Why?
|
Tritium | 1 | 2004 | 51 | 0.060 |
Why?
|
Serotonin | 1 | 2005 | 123 | 0.060 |
Why?
|
Radioligand Assay | 1 | 2004 | 66 | 0.060 |
Why?
|
Dizocilpine Maleate | 1 | 2004 | 48 | 0.060 |
Why?
|
Binding, Competitive | 1 | 2004 | 111 | 0.060 |
Why?
|
Hyperkinesis | 1 | 2003 | 7 | 0.060 |
Why?
|
Protein Methyltransferases | 1 | 2003 | 6 | 0.060 |
Why?
|
Cyclic AMP | 1 | 2004 | 131 | 0.060 |
Why?
|
Amphetamine | 1 | 2003 | 16 | 0.060 |
Why?
|
Receptors, Dopamine D2 | 1 | 2004 | 73 | 0.060 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2004 | 99 | 0.060 |
Why?
|
Body Temperature | 1 | 2003 | 36 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2004 | 168 | 0.060 |
Why?
|
Tissue Distribution | 1 | 2004 | 207 | 0.060 |
Why?
|
Benzamides | 1 | 2004 | 78 | 0.060 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2004 | 77 | 0.060 |
Why?
|
Tremor | 2 | 1993 | 9 | 0.060 |
Why?
|
Triazoles | 1 | 2003 | 86 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2005 | 893 | 0.050 |
Why?
|
Intracellular Fluid | 1 | 2002 | 26 | 0.050 |
Why?
|
Culture Media, Conditioned | 1 | 2002 | 46 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2004 | 550 | 0.050 |
Why?
|
bcl-2-Associated X Protein | 1 | 2002 | 77 | 0.050 |
Why?
|
Structure-Activity Relationship | 1 | 2003 | 409 | 0.050 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2002 | 62 | 0.050 |
Why?
|
DNA Fragmentation | 1 | 2002 | 92 | 0.050 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2002 | 78 | 0.050 |
Why?
|
Cell Membrane | 1 | 2004 | 381 | 0.050 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 2231 | 0.050 |
Why?
|
Liver | 1 | 2005 | 479 | 0.050 |
Why?
|
Central Nervous System Stimulants | 1 | 2003 | 174 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 152 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2003 | 433 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2004 | 1039 | 0.050 |
Why?
|
Protein Binding | 1 | 2004 | 972 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2002 | 239 | 0.050 |
Why?
|
Proteins | 1 | 2002 | 369 | 0.040 |
Why?
|
Organ Specificity | 2 | 2004 | 129 | 0.030 |
Why?
|
Immobilization | 1 | 1993 | 9 | 0.030 |
Why?
|
Histocytochemistry | 1 | 1992 | 50 | 0.030 |
Why?
|
Drug Interactions | 1 | 1993 | 141 | 0.030 |
Why?
|
Chromatography, Ion Exchange | 1 | 1992 | 25 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 1993 | 196 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 1992 | 136 | 0.020 |
Why?
|
Inhalation | 1 | 1988 | 8 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1988 | 133 | 0.020 |
Why?
|
Phosphatidylethanolamines | 1 | 2005 | 27 | 0.020 |
Why?
|
Phosphatidylcholines | 1 | 2005 | 47 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2004 | 225 | 0.010 |
Why?
|
Humans | 1 | 2006 | 37093 | 0.010 |
Why?
|